Persefoni has 4 years’ experience in market access consultancy. She has led a range of projects to support market access and reimbursement activities for pharmaceuticals, medical devices and diagnostics. These include: HTA submissions (within the UK and Republic of Ireland), value proposition/value message development and testing, global value dossier development, early drug pipeline assessments, HTA reviews, advisory boards, scientific manuscripts, and systematic/targeted literature reviews. She has worked in a range of disease areas, including oncology, musculoskeletal, neurological, renal, gastrointestinal, and mental health disorders.
Persefoni holds a PhD in Medical Genetics, which focused on Duchenne muscular dystrophy, as well as an MSc in Genetics and BSc in Biomedical Science.